Ann Thompson Email

VP, Global Health Economics, Reimbursement and Policy . AxoGen

Current Roles

Employees:
409
Revenue:
$83.9M
About
It's time to rethink nerve repair! AxoGen (NASDAQ: AXGN) is a medical products company with a portfolio of proprietary products and technologies for peripheral nerve reconstruction and regeneration. People suffer traumatic injuries or undergo surgeries that impact the function of their peripheral nerves daily. Damage may cause loss of function and feeling. AxoGen is bringing the science of nerve repair to life with its Avance® Nerve Graft which AxoGen believes is the first and only commercially available allograft for bridging nerve discontinuities, AxoGuard® Nerve Connector, a coaptation aid allowing for close approximation of severed nerves, and AxoGuard® Nerve Protector that protects nerves during the healing process.
AxoGen Address
13631 Progress Blvd
Alachua, FL
United States

Past Companies

axogenVice President, Global Health Economics, Reimbursement and Policy
Edwards LifesciencesSr. Director, Health Economics and Reimbursement
Johnson & Johnson Medical Devices CompaniesDirector, Payor Relations

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.